Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
OEC vs CBT
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
OEC vs CBT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $461M | $4.30B |
| Revenue (TTM) | $1.79B | $3.58B |
| Net Income (TTM) | $-89M | $285M |
| Gross Margin | 19.1% | 24.8% |
| Operating Margin | 4.5% | 15.7% |
| Forward P/E | 36.4x | 13.2x |
| Total Debt | $980M | $1.22B |
| Cash & Equiv. | $61M | $258M |
OEC vs CBT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Orion Engineered Ca… (OEC) | 100 | 74.1 | -25.9% |
| Cabot Corporation (CBT) | 100 | 230.7 | +130.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OEC vs CBT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
OEC is the clearest fit if your priority is growth exposure.
- Rev growth -3.8%, EPS growth -263.2%, 3Y rev CAGR -3.8%
- -3.8% revenue growth vs CBT's -7.0%
CBT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 4 yrs, beta 0.78, yield 2.1%
- 115.6% 10Y total return vs OEC's -23.8%
- Lower volatility, beta 0.78, Low D/E 71.3%, current ratio 1.61x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -3.8% revenue growth vs CBT's -7.0% | |
| Value | Lower P/E (13.2x vs 36.4x) | |
| Quality / Margins | 8.0% margin vs OEC's -5.0% | |
| Stability / Safety | Beta 0.78 vs OEC's 1.39, lower leverage | |
| Dividends | 2.1% yield, 4-year raise streak, vs OEC's 1.0% | |
| Momentum (1Y) | +16.2% vs OEC's -27.8% | |
| Efficiency (ROA) | 7.4% ROA vs OEC's -4.6%, ROIC 17.4% vs 5.5% |
OEC vs CBT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
OEC vs CBT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CBT leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CBT is the larger business by revenue, generating $3.6B annually — 2.0x OEC's $1.8B. CBT is the more profitable business, keeping 8.0% of every revenue dollar as net income compared to OEC's -5.0%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.8B | $3.6B |
| EBITDAEarnings before interest/tax | $180M | $731M |
| Net IncomeAfter-tax profit | -$89M | $285M |
| Free Cash FlowCash after capex | $68M | $459M |
| Gross MarginGross profit ÷ Revenue | +19.1% | +24.8% |
| Operating MarginEBIT ÷ Revenue | +4.5% | +15.7% |
| Net MarginNet income ÷ Revenue | -5.0% | +8.0% |
| FCF MarginFCF ÷ Revenue | +3.8% | +12.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.8% | -3.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.1% | -23.1% |
Valuation Metrics
OEC leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, OEC's 5.9x EV/EBITDA is more attractive than CBT's 6.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $461M | $4.3B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $5.3B |
| Trailing P/EPrice ÷ TTM EPS | -6.61x | 13.69x |
| Forward P/EPrice ÷ next-FY EPS est. | 36.36x | 13.23x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 5.91x | 6.79x |
| Price / SalesMarket cap ÷ Revenue | 0.26x | 1.16x |
| Price / BookPrice ÷ Book value/share | 1.20x | 2.62x |
| Price / FCFMarket cap ÷ FCF | 9.19x | 11.01x |
Profitability & Efficiency
CBT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CBT delivers a 16.8% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-22 for OEC. CBT carries lower financial leverage with a 0.71x debt-to-equity ratio, signaling a more conservative balance sheet compared to OEC's 2.55x. On the Piotroski fundamental quality scale (0–9), CBT scores 6/9 vs OEC's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -21.8% | +16.8% |
| ROA (TTM)Return on assets | -4.6% | +7.4% |
| ROICReturn on invested capital | +5.5% | +17.4% |
| ROCEReturn on capital employed | +7.8% | +21.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 2.55x | 0.71x |
| Net DebtTotal debt minus cash | $919M | $957M |
| Cash & Equiv.Liquid assets | $61M | $258M |
| Total DebtShort + long-term debt | $980M | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | -0.14x | 14.72x |
Total Returns (Dividends Reinvested)
CBT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CBT five years ago would be worth $14,375 today (with dividends reinvested), compared to $3,861 for OEC. Over the past 12 months, CBT leads with a +16.2% total return vs OEC's -27.8%. The 3-year compound annual growth rate (CAGR) favors CBT at 7.5% vs OEC's -29.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +56.3% | +23.6% |
| 1-Year ReturnPast 12 months | -27.8% | +16.2% |
| 3-Year ReturnCumulative with dividends | -64.7% | +24.1% |
| 5-Year ReturnCumulative with dividends | -61.4% | +43.8% |
| 10-Year ReturnCumulative with dividends | -23.8% | +115.6% |
| CAGR (3Y)Annualised 3-year return | -29.3% | +7.5% |
Risk & Volatility
CBT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CBT is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than OEC's 1.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 97.4% from its 52-week high vs OEC's 67.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.39x | 0.78x |
| 52-Week HighHighest price in past year | $12.10 | $84.60 |
| 52-Week LowLowest price in past year | $4.35 | $58.33 |
| % of 52W HighCurrent price vs 52-week peak | +67.8% | +97.4% |
| RSI (14)Momentum oscillator 0–100 | 78.0 | 63.9 |
| Avg Volume (50D)Average daily shares traded | 612K | 371K |
Analyst Outlook
CBT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates OEC as "Buy" and CBT as "Buy". Consensus price targets imply -5.4% upside for CBT (target: $78) vs -28.3% for OEC (target: $6). For income investors, CBT offers the higher dividend yield at 2.15% vs OEC's 1.02%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $5.88 | $78.00 |
| # AnalystsCovering analysts | 14 | 15 |
| Dividend YieldAnnual dividend ÷ price | +1.0% | +2.1% |
| Dividend StreakConsecutive years of raises | 3 | 4 |
| Dividend / ShareAnnual DPS | $0.08 | $1.77 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.4% | +3.9% |
CBT leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). OEC leads in 1 (Valuation Metrics).
OEC vs CBT: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is OEC or CBT a better buy right now?
For growth investors, Orion Engineered Carbons S.
A. (OEC) is the stronger pick with -3. 8% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 13. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Orion Engineered Carbons S. A. (OEC) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OEC or CBT?
On forward P/E, Cabot Corporation is actually cheaper at 13.
2x.
03Which is the better long-term investment — OEC or CBT?
Over the past 5 years, Cabot Corporation (CBT) delivered a total return of +43.
8%, compared to -61. 4% for Orion Engineered Carbons S. A. (OEC). Over 10 years, the gap is even starker: CBT returned +115. 6% versus OEC's -23. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OEC or CBT?
By beta (market sensitivity over 5 years), Cabot Corporation (CBT) is the lower-risk stock at 0.
78β versus Orion Engineered Carbons S. A. 's 1. 39β — meaning OEC is approximately 77% more volatile than CBT relative to the S&P 500. On balance sheet safety, Cabot Corporation (CBT) carries a lower debt/equity ratio of 71% versus 3% for Orion Engineered Carbons S. A. — giving it more financial flexibility in a downturn.
05Which is growing faster — OEC or CBT?
By revenue growth (latest reported year), Orion Engineered Carbons S.
A. (OEC) is pulling ahead at -3. 8% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: Cabot Corporation grew EPS -10. 4% year-over-year, compared to -263. 2% for Orion Engineered Carbons S. A.. Over a 3-year CAGR, OEC leads at -3. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — OEC or CBT?
Cabot Corporation (CBT) is the more profitable company, earning 8.
9% net margin versus -3. 9% for Orion Engineered Carbons S. A. — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus 5. 6% for OEC. At the gross margin level — before operating expenses — CBT leads at 25. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is OEC or CBT more undervalued right now?
On forward earnings alone, Cabot Corporation (CBT) trades at 13.
2x forward P/E versus 36. 4x for Orion Engineered Carbons S. A. — 23. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CBT: -5. 4% to $78. 00.
08Which pays a better dividend — OEC or CBT?
All stocks in this comparison pay dividends.
Cabot Corporation (CBT) offers the highest yield at 2. 1%, versus 1. 0% for Orion Engineered Carbons S. A. (OEC).
09Is OEC or CBT better for a retirement portfolio?
For long-horizon retirement investors, Cabot Corporation (CBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
78), 2. 1% yield, +115. 6% 10Y return). Both have compounded well over 10 years (CBT: +115. 6%, OEC: -23. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between OEC and CBT?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: OEC is a small-cap quality compounder stock; CBT is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.